Literature DB >> 11815356

Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C.

Carol L Shields, Hakan Demirci, Jerry A Shields, Christopher Spanich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11815356      PMCID： PMC1770995          DOI： 10.1136/bjo.86.2.244

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

Review 1.  Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture.

Authors:  J A Shields; C L Shields; P De Potter
Journal:  Arch Ophthalmol       Date:  1997-06

2.  Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.

Authors:  H Demirci; S A McCormick; P T Finger
Journal:  Arch Ophthalmol       Date:  2000-07

3.  Clinical characterization of primary acquired melanosis.

Authors:  P Gloor; G Alexandrakis
Journal:  Gaz Med Fr       Date:  1995-07

4.  Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.

Authors:  J Frucht-Pery; J Sugar; J Baum; J E Sutphin; J Pe'er; H Savir; E J Holland; D M Meisler; J A Foster; R Folberg; Y Rozenman
Journal:  Ophthalmology       Date:  1997-12       Impact factor: 12.079

5.  Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.

Authors:  C L Shields; J A Shields; K Gündüz; J Cater; G V Mercado; N Gross; B Lally
Journal:  Arch Ophthalmol       Date:  2000-11

6.  Conjunctival melanosis and melanoma.

Authors:  R Folberg; I W McLean; L E Zimmerman
Journal:  Ophthalmology       Date:  1984-06       Impact factor: 12.079
  6 in total
  2 in total

1.  Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.

Authors:  Madhavi Kurli; Paul T Finger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-07       Impact factor: 3.117

Review 2.  Tumors of the conjunctiva and cornea.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.